SE7413832L - - Google Patents

Info

Publication number
SE7413832L
SE7413832L SE7413832A SE7413832A SE7413832L SE 7413832 L SE7413832 L SE 7413832L SE 7413832 A SE7413832 A SE 7413832A SE 7413832 A SE7413832 A SE 7413832A SE 7413832 L SE7413832 L SE 7413832L
Authority
SE
Sweden
Application number
SE7413832A
Other versions
SE415761B (sv
Inventor
R A Archer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7413832L publication Critical patent/SE7413832L/xx
Publication of SE415761B publication Critical patent/SE415761B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)
SE7413832A 1973-11-05 1974-11-04 Forfarande for framstellning av hexahydro-dibenso(b,d)pyran-9-on-derivat med terapeutisk verkan SE415761B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US413009A US3928598A (en) 1973-11-05 1973-11-05 Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug

Publications (2)

Publication Number Publication Date
SE7413832L true SE7413832L (pl) 1975-05-06
SE415761B SE415761B (sv) 1980-10-27

Family

ID=23635412

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7413832A SE415761B (sv) 1973-11-05 1974-11-04 Forfarande for framstellning av hexahydro-dibenso(b,d)pyran-9-on-derivat med terapeutisk verkan

Country Status (25)

Country Link
US (1) US3928598A (pl)
JP (1) JPS6033834B2 (pl)
AR (1) AR206409A1 (pl)
AT (1) AT337178B (pl)
BE (1) BE821719A (pl)
BG (1) BG25995A3 (pl)
CA (1) CA1029383A (pl)
CH (1) CH611290A5 (pl)
CS (1) CS193506B2 (pl)
DD (1) DD116229A5 (pl)
DE (1) DE2451932C2 (pl)
DK (1) DK136718B (pl)
ES (1) ES431675A1 (pl)
FR (1) FR2249663B1 (pl)
GB (1) GB1487636A (pl)
HU (1) HU169192B (pl)
IE (1) IE40025B1 (pl)
IL (1) IL45662A (pl)
NL (1) NL180979C (pl)
PH (1) PH10476A (pl)
PL (2) PL94965B1 (pl)
SE (1) SE415761B (pl)
SU (1) SU515457A3 (pl)
YU (1) YU36946B (pl)
ZA (1) ZA745794B (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4102902A (en) * 1976-11-10 1978-07-25 Eli Lilly And Company Stereoselective preparation of hexahydro dibenzopyranones and intermediates therefor
US4309545A (en) * 1980-07-28 1982-01-05 Pfizer Inc. Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof
US4351833A (en) * 1980-07-28 1982-09-28 Pfizer Inc. 9-Amino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof as analgesics and anti-emetics
US5498419A (en) * 1994-06-03 1996-03-12 Pars; Harry G. Fumarate salt of 4-(diethyl-3-(1-methyloctyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol, 4-(diethyl-amino) butyric
CA2340445A1 (en) * 1998-05-04 1999-11-11 The University Of Connecticut Novel analgesic and immunomodulatory cannabinoids
US7589220B2 (en) * 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
US7897598B2 (en) * 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US8084467B2 (en) * 1999-10-18 2011-12-27 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US7741365B2 (en) * 1999-10-18 2010-06-22 University Of Connecticut Peripheral cannabinoid receptor (CB2) selective ligands
US6943266B1 (en) * 1999-10-18 2005-09-13 University Of Connecticut Bicyclic cannabinoid agonists for the cannabinoid receptor
US6900236B1 (en) 1999-10-18 2005-05-31 University Of Connecticut Cannabimimetic indole derivatives
WO2001028329A1 (en) 1999-10-18 2001-04-26 University Of Connecticut Peripheral cannabinoid receptor (cb2) selective ligands
US7119108B1 (en) 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
AU2001296402A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
US6541510B2 (en) * 2000-09-28 2003-04-01 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
US7329651B2 (en) * 2001-01-26 2008-02-12 University Of Connecticut Cannabimimetic ligands
WO2002060447A1 (en) 2001-01-29 2002-08-08 University Of Connecticut Receptor selective cannabimimetic aminoalkylindoles
WO2003005960A2 (en) * 2001-07-13 2003-01-23 University Of Connecticut Novel bicyclic and tricyclic cannabinoids
WO2003035005A2 (en) * 2001-10-26 2003-05-01 University Of Connecticut Heteroindanes: a new class of potent cannabimimetic ligands
WO2003080043A1 (en) * 2002-03-18 2003-10-02 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
AU2003265663A1 (en) 2002-08-23 2004-03-11 University Of Connecticut Keto cannabinoids with therapeutic indications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones

Also Published As

Publication number Publication date
AU7329074A (en) 1976-03-18
NL180979C (nl) 1987-06-01
US3928598A (en) 1975-12-23
YU261974A (en) 1982-06-18
PH10476A (en) 1977-05-11
NL7414437A (nl) 1975-05-07
ZA745794B (en) 1976-04-28
AR206409A1 (es) 1976-07-23
JPS5082073A (pl) 1975-07-03
DE2451932C2 (de) 1983-09-29
DD116229A5 (pl) 1975-11-12
IL45662A0 (en) 1974-11-29
CA1029383A (en) 1978-04-11
CS193506B2 (en) 1979-10-31
NL180979B (nl) 1987-01-02
ES431675A1 (es) 1977-04-16
BG25995A3 (bg) 1979-01-12
HU169192B (pl) 1976-10-28
FR2249663A1 (pl) 1975-05-30
ATA886274A (de) 1976-10-15
JPS6033834B2 (ja) 1985-08-05
PL100502B1 (pl) 1978-10-31
AT337178B (de) 1977-06-10
DK573174A (pl) 1975-07-07
SE415761B (sv) 1980-10-27
PL94965B1 (pl) 1977-09-30
DK136718B (da) 1977-11-14
DK136718C (pl) 1978-04-24
DE2451932A1 (de) 1975-05-07
YU36946B (en) 1984-08-31
GB1487636A (en) 1977-10-05
FR2249663B1 (pl) 1978-03-24
IL45662A (en) 1978-03-10
BE821719A (fr) 1975-04-30
SU515457A3 (ru) 1976-05-25
IE40025B1 (en) 1979-02-28
IE40025L (en) 1975-05-05
CH611290A5 (pl) 1979-05-31

Similar Documents

Publication Publication Date Title
AR201758A1 (pl)
AU465372B2 (pl)
AR201235Q (pl)
AR201231Q (pl)
AU474593B2 (pl)
DK136718C (pl)
AU465453B2 (pl)
AU471343B2 (pl)
AU465434B2 (pl)
AU450229B2 (pl)
AU476714B2 (pl)
AR201229Q (pl)
AU476696B2 (pl)
AU466283B2 (pl)
AR199451A1 (pl)
AU472848B2 (pl)
AU476873B1 (pl)
AU477823B2 (pl)
AR210729A1 (pl)
AR200885A1 (pl)
AR196382A1 (pl)
AU477824B2 (pl)
AR197627A1 (pl)
AR200256A1 (pl)
AR193950A1 (pl)

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7413832-2

Effective date: 19941210

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7413832-2

Format of ref document f/p: F